Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Abaloparatide is more potent than teriparatide in restoring bone mass and strength in type 1 diabetic male mice

Bone(2024)10.1016/j.bone.2024.117042Source: DataRank Database

Abaloparatide is more potent than teriparatide in restoring bone mass and strength in type 1 diabetic male mice is a research paper published in Bone (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 1.17)OA: greenTopics (34)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Serra Ucer Ozgurel ORCID,Kevin McAndrews ORCID,Meloney Cregor,Alma Villaseñor ORCID,Maricruz Mamani‐Huanca ORCID

Live enrichment

PubMed:38360197 PMC:PMC13147481 OpenAlex:https://openalex.org/W4391787621

National Institutes of Health

Grant: R01-AR059357

National Institutes of Health

Grant: T32-AR065971

U.S. Department of Veterans Affairs

Grant: I01 BX002104

U.S. Department of Veterans Affairs

Grant: IK6BX004596

NIAMS NIH HHS

Grant: R01 AR059357

NIAMS NIH HHS

Grant: T32 AR065971

Veterans Health Administration Biomedical Laboratory Research and Development

American Society of Hematology

FWCI

1.17

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC13147481/

publisherhttps://api.elsevier.com/content/article/PII:S8756328224000310?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S8756328224000310?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.bone.2024.117042

Fields of Study

Diet and metabolism studiesMetabolism, Diabetes, and CancerGrowth Hormone and Insulin-like Growth FactorsHumansMiceMaleAnimalsInfant, NewbornTeriparatideDiabetes Mellitus, Type 1Bone DensityParathyroid Hormone-Related ProteinParathyroid Hormone

MeSH Terms

AnimalsDiabetes Mellitus, Type 1HumansInfant, NewbornMaleParathyroid HormoneBone DensityTeriparatideParathyroid Hormone-Related ProteinMice

Keywords

TeriparatideBone massEndocrinologyMedicineInternal medicineOsteoporosisBone mineralPTHDiabetesBoneAbaloparatide

Sustainable Development Goals

SDG 0: Good health and well-being